Quarry LP’s Pfizer PFE Stock Holding History

Quarry LP’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-600,000	Closed	-$17.3M	–	1850
2023 Q4	$17.3M	Buy	600,000 +340,000	+131%	+$10.3M	2.67%	8
2023 Q3	$8.62M	Buy	+260,000	New	+$9.19M	2.01%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quarry LP's PFE Position: Q4 2024 in Review

Quarry LP sold out of Pfizer (PFE) in Q4 2024, closing a stake of 16,462 shares — an estimated $476K sold.

Quarry LP first reported a position in PFE in Q2 2024 and held it in 2 quarters. The position peaked at $476K in Q3 2024. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Quarry LP reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
Quarry LP sold 16,462 Pfizer shares in Q4 2024, an estimated $476K.
Quarry LP first reported a position in Pfizer in Q2 2024 and held it in 2 quarters.
Quarry LP's Pfizer position peaked at $476K in Q3 2024.
2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Quarry LP's 13F filing for Q4 2024, filed 14 Feb 2025.